bromocriptine has been researched along with methotrexate in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Martin, JB; Riskind, PN | 1 |
| Hofmann, W; Langkopf, B | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Bavli, IaL; Moiseenko, VM; Semiglazov, VF | 1 |
| Sahn, SA | 1 |
| Farajzadegan, Z; Hajalikhani, M; Namdarigharaghani, N; Nasri, P; Sadeghihaddadzavareh, S; Salesi, M | 1 |
| Aghajanzadeh, M; Alavi, A; Alizadeh Sefat, S; Emir Alavi, C; Esmaeili Delshad, MS; Geranmayeh, S; Habibzadeh, SM; Hassanzadeh, R; Hemmati, H; Massahniya, S; Najafi Ashtiani, M; Rasam, K; Rimaz, S | 1 |
3 review(s) available for bromocriptine and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
3 trial(s) available for bromocriptine and methotrexate
| Article | Year |
|---|---|
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
[Adjuvant therapy of breast cancer patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Random Allocation; Tamoxifen; Thiotepa | 1986 |
The role of bromocriptine in the treatment of patients with active rheumatoid arthritis.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Male; Methotrexate; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
11 other study(ies) available for bromocriptine and methotrexate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
Neurologic manifestations of hypothalamic disease.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Hypothalamic Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Mannitol; Methotrexate; Middle Aged; Prednisone; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
[Chemotherapy of advanced prostate cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cyproterone; Cyproterone Acetate; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms | 1986 |
Granulomatous mastitis: Presentations, diagnosis, treatment and outcome in 206 patients from the north of Iran.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Biopsy, Needle; Breast; Bromocriptine; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Iran; Mammography; Methotrexate; Retrospective Studies; Treatment Outcome; Ultrasonography, Mammary; Young Adult | 2015 |